accesso® Unveils accessoPay 3.0
Smart, Streamlined Checkout Experiences for the Next-Gen Guest ORLANDO, Fla., Aug. 19, 2025 /PRNewswire/ — accesso Technology Group (AIM: ACSO), the premier... Read more.
DXC and Boomi Forge Strategic Partnership to Fast-Track Modernization and Adoption of Agentic AI
New Boomi Center of Excellence (COE) within DXC will act as an innovation hub for customers across industries DXC and Boomi help customers unify AI agents to prepare... Read more.
Steel Dynamics to Acquire Remaining 55% Ownership Interest in New Process Steel
FORT WAYNE, Ind., Aug. 19, 2025 /PRNewswire/ — Steel Dynamics, Inc. (NASDAQ/GS: STLD) today announced that it has entered into a definitive agreement to acquire... Read more.
Madison Street Capital Acts as Exclusive Financial Advisor to SBS Precision Sheet Metal, LLC (“SBS Precision”) on its Sale to Appian Way Capital Partners, LLC (“Appian Way”)
AUSTIN, Texas, Aug. 19, 2025 /PRNewswire/ — Madison Street Capital, an international investment banking firm, acted as the exclusive financial advisor on the... Read more.
Shipt to Launch Alabama’s First Portable Benefits Program for Shoppers
Portable benefits program to allow shoppers with Shipt to receive contributions that support financial goals, maintain work schedule flexibility BIRMINGHAM, Ala.,... Read more.
AirNet Technology Inc. Engages Raeez Lorgat as Strategic Advisor to Advance Fintech and Blockchain Expansion
BEIJING, Aug. 19, 2025 /PRNewswire/ — AirNet Technology Inc. (NASDAQ: ANTE) (“AirNet” or the “Company”) today announced it has engaged... Read more.
Building Trustworthy AI Starts with Data Confidence, According to Protiviti Study
MENLO PARK, Calif., Aug. 19, 2025 /PRNewswire/ — AI success is built on strong data, with 69% of organizations that have high AI maturity saying they are “very... Read more.
Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)
MAHWAH, N.J., Aug. 19, 2025 /PRNewswire/ — Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch1 of Micafungin for Injection... Read more.
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC
CHENGDU, China, Aug. 19, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”, HKEX: 6990) announced that clinical... Read more.
ITURAN LOCATION AND CONTROL LTD Announces Dividend Distribution of $10 Million for the Second Quarter of 2025
AZOUR, Israel, Aug. 19, 2025 /PRNewswire/ — Ituran Location and Control Ltd. (NASDAQ: ITRN) announced that the Board of Directors approved the distribution... Read more.